Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04511039
What this trial is testing

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Gastroesophageal Junction AdenocarcinomaClinical Stage IV Gastroesophageal Junction Adenocarcinoma+26 more
Roswell Park Cancer Institute 45
Early research (Phase 1)Active Not RecruitingNCT03589339
What this trial is testing

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Who this might be right for
RadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more
Nanobiotix 145
Testing effectiveness (Phase 2)Looking for participantsNCT04807257
What this trial is testing

Auger Molecular Therapy (AMT) for Malignant Cutaneous Lesions Treatment

Who this might be right for
Malignant Fungating Wound
NanoRay Biotech Co., Ltd. 18
Early research (Phase 1)UnknownNCT05848999
What this trial is testing

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Who this might be right for
Mesothelin-positive Advanced Malignant Solid Tumors
Zhejiang University 87
Early research (Phase 1)Not Yet RecruitingNCT07566247
What this trial is testing

A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor

Who this might be right for
Advanced Malignant Solid Tumors
Akeso 96
Testing effectiveness (Phase 2)Study completedNCT01634555
What this trial is testing

Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI

Who this might be right for
Solid Tumors
Eli Lilly and Company 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT05103358
What this trial is testing

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

Who this might be right for
TumorTumor, SolidMetastasis+18 more
Aadi Bioscience, Inc. 120
Early research (Phase 1)Study completedNCT06253195
What this trial is testing

BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorHormone-receptor-positive Breast Cancer+4 more
BeOne Medicines 33
Testing effectiveness (Phase 2)Temporarily pausedNCT02130492
What this trial is testing

A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)

Who this might be right for
Advanced Cancer
Weill Medical College of Cornell University 30
Early research (Phase 1)Looking for participantsNCT06912152
What this trial is testing

MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors

Who this might be right for
B7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors
Zhejiang University 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06303167
What this trial is testing

Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00725634
What this trial is testing

Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma

Who this might be right for
Malignant Solid TumorLymphomasMultiple Myeloma
AVEO Pharmaceuticals, Inc. 41
Testing effectiveness (Phase 2)Looking for participantsNCT07102004
What this trial is testing

Study of MHB088C for Patients With Advanced Solid Malignant Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
Qilu Pharmaceutical Co., Ltd. 515
Early research (Phase 1)Ended earlyNCT00195247
What this trial is testing

Study Evaluating TTI-237 in Advanced Malignant Solid Tumors

Who this might be right for
Neoplasms
Wyeth is now a wholly owned subsidiary of Pfizer 45
Early research (Phase 1)Study completedNCT00782002
What this trial is testing

Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 27
Early research (Phase 1)WithdrawnNCT01521299
What this trial is testing

A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors

Who this might be right for
Advanced Solid Tumors
Dartmouth-Hitchcock Medical Center
Early research (Phase 1)Looking for participantsNCT06764771
What this trial is testing

BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Bristol-Myers Squibb 437
Testing effectiveness (Phase 2)WithdrawnNCT06400264
What this trial is testing

Testing Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01713972
What this trial is testing

Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Manisha Shah 23
Testing effectiveness (Phase 2)Looking for participantsNCT07697937
What this trial is testing

YH02 Injection for Intra-tumor Injection Therapy in Advanced Solid Tumors With Unresponsive or Failure-Treated Cases

Who this might be right for
Advanced Malignant Solid Tumor
Tianjin First Central Hospital 50
Next Page